Vaxart updates BARDA funding for COVID-19 oral vaccine trial
Vaxart received additional BARDA funding to advance COVID-19 vaccine data analysis. The release allows the company to report 12-month trial data.
View filing at SEC.gov →1 most recent filing and news item mentioning VXRT. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/VXRT/news?limit=20"
Pull VXRT filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayVaxart received additional BARDA funding to advance COVID-19 vaccine data analysis. The release allows the company to report 12-month trial data.
View filing at SEC.gov →